Skip to main content
Caplight Logo









AiCure

AiCure

Private
New York City, New YorkHealthcare & Life Scienceshttps://aicure.com/

Last Round

VC Round

Jan 23, 2024

Total Funding Raised

$58.75M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

AiCure is a health technology company that provides an AI and advanced data analytics platform to monitor patient behavior and improve clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical AI, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

digital biomarkersmedication adherenceclinical trial AIremote patient monitoringpatient engagement platformdecentralized clinical trialsDCTvirtual clinical trialseCOAhealthcare computer visionbehavioral data analysishybrid clinical trialsclinical trial technologyePROcontract research organizationCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AiCure Comparables

Compare AiCure with similar companies based on industry and business-model similarity.

AiCure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Datacubed Health
87%
Koneksa Health
81%
ObvioHealth
81%

AiCure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 23, 2024
Series CNov 7, 2019
Series BNov 17, 2017
Series AJan 11, 2016

Key People

Founding team and executive leadership

Edward Ikeguchi

Chief Executive Officer

Executive Team

AiCure Investors

Notable investors and investment history

AiCure investors
InvestorRounds
New Leaf Venture PartnersSeries C, Series B, Series A
Palisades GrowthSeries C
NIH RADxGrant
Pritzker Group Venture CapitalSeries C, Series A, Series B
Biomatics Capital PartnersSeries C, Series A, Series B
Baird CapitalSeries C, Series B
SpringRock VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 199, 510% of current headcount.

  • Jul 10, 2025

    Monthly visitors increased 576% MoM, reaching 14.2K.

Recent news

Latest coverage and updates

  • launchesJul 17, 2026

    AICure Corporation launched WeightVerify platform on Jul 17th '26.

AiCure Filings

Explore SEC and related filing metadata, where available.

AiCure filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AiCure's valuation, stock price, and market status.

Is AiCure a public or private company?

AiCure is a private company.

What is the current stock price of AiCure?

AiCure is a private company with no public stock price. No recent secondary market data is available.

How much is AiCure worth (valuation)?

Valuation information for AiCure is not publicly available.

Can I buy AiCure stock?

AiCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AiCure's last funding round?

AiCure's most recent funding round was VC Round on January 23, 2024.

Who are the main investors in AiCure?

Key investors in AiCure include New Leaf Venture Partners, Palisades Growth, Baird Capital.

Will AiCure IPO soon?

No public IPO plans have been announced for AiCure.

How can I track AiCure secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AiCure's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range40
Year Founded2010
Last FundingJan 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?